Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2023
Echocardiography to Assess Cardiac Structure and Function in Genetic CardiomyopathiesGalina Flint, Kristina Kooiker, Farid Moussavi-HaramiCell Stem Cell|February 17, 2022
MBNL1 drives dynamic transitions between fibroblasts and myofibroblasts in cardiac wound healingDarrian Bugg, Logan R J Bailey, Ross C Bretherton, et al.The Journal of General Physiology|July 31, 2024
Mechanisms of a novel regulatory light chain-dependent cardiac myosin inhibitorKristina Kooiker, Qing-Fen Gan, Ming Yu, et al.Journal of Molecular and Cellular Cardiology|December 5, 2022
dATP elevation induces myocardial metabolic remodeling to support improved cardiac functionKetaki N Mhatre, Jason D Murray, Galina Flint, et al.Biorxiv : the Preprint Server for Biology|June 4, 2025
Myosin modulator Aficamten inhibits force in cardiac muscle by altering myosin's biochemical activity without changing thick filament structureSaffie Mohran, Kristina B Kooiker, Ateeqa Naim, et al.JACC. Basic to Translational Science|December 20, 2025
Myosin Modulator Aficamten Inhibits Force by Altering Myosin's Biochemical Activity Without Changing Thick Filament StructureSaffie Mohran, Kristina B Kooiker, Ateeqa Naim, et al.Biorxiv : the Preprint Server for Biology|May 10, 2023
Cell based dATP delivery as a therapy for chronic heart failureKetaki N Mhatre, Julie Mathieu, Amy Martinson, et al.Biorxiv : the Preprint Server for Biology|February 13, 2023
Danicamtiv increases myosin recruitment and alters the chemomechanical cross bridge cycle in cardiac muscleKristina B Kooiker, Saffie Mohran, Kyrah L Turner, et al.Circulation Research|July 20, 2023
Danicamtiv Increases Myosin Recruitment and Alters Cross-Bridge Cycling in Cardiac MuscleKristina B Kooiker, Saffie Mohran, Kyrah L Turner, et al.Pageof 1